Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Fan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6971-1164; OpenAlex author ID A5100342355, A5100403592. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 7

  1. Correction to "Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer". Co-author DOI 10.1021/acsnano.5c06828↗
  2. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. Co-author DOI 10.1016/j.bioorg.2023.106937↗
  3. Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer. Co-author DOI 10.2478/jtim-2023-0128↗
  4. Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report. Co-author DOI 10.1097/cad.0000000000001334↗
  5. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13045-022-01384-3↗
  6. Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort. Co-author DOI 10.2147/tcrm.s173041↗
  7. Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acsnano.7b08225↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan Liu · 2 shared papers, 2017–2025 · strength 0.33
  2. Jie Chen · 2 shared papers, 2017–2025 · strength 0.33
  3. Junjie Liu · 1 shared paper, 2025 · strength 0.26
  4. Fengna Liu · 1 shared paper, 2024 · strength 0.24
  5. Mingzhou Guo · 1 shared paper, 2024 · strength 0.24
  6. Wing‐Leung Wong · 1 shared paper, 2024 · strength 0.18
  7. Dongli Li · 1 shared paper, 2024 · strength 0.18
  8. Panpan Wu · 1 shared paper, 2024 · strength 0.18
  9. Xuetao Xu · 1 shared paper, 2024 · strength 0.18
  10. Xi Zheng · 1 shared paper, 2024 · strength 0.18
  11. Peng Hong · 1 shared paper, 2024 · strength 0.18
  12. Yibing Liu · 1 shared paper, 2022 · strength 0.15
  13. Xiaomin Li · 1 shared paper, 2022 · strength 0.15
  14. Wenhui Lou · 1 shared paper, 2022 · strength 0.11
  15. Yexin Tong · 1 shared paper, 2022 · strength 0.11
  16. Yuan Ji Ma · 1 shared paper, 2022 · strength 0.11
  17. Li Yan · 1 shared paper, 2022 · strength 0.11
  18. Chen Ding · 1 shared paper, 2022 · strength 0.11
  19. Junxun Ma · 1 shared paper, 2018 · strength 0.08
  20. Danyang Sun · 1 shared paper, 2018 · strength 0.08
  21. Yi Hu · 1 shared paper, 2018 · strength 0.08
  22. Junjie Liu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.